up 269-6 has been researched along with angiotensin ii in 7 studies
Studies (up 269-6) | Trials (up 269-6) | Recent Studies (post-2010) (up 269-6) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
15 | 4 | 0 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | up 269-6 (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunner, HR; Hagmann, M; Hiesse-Provost, O; Inglessis, N; Insuasty, J; Ménard, J; Nussberger, J; Reid, J | 1 |
Brunner, HR; Insuasty, J; MacFadyen, RJ; McIntyre, M; Menard, J; Meredith, PA; Reid, JL | 1 |
Caussade, F; Cazes, M; Cloarec, A; Delchambre, C; Versigny, A; Virone-Oddos, A | 1 |
Cazes, M; Cloarec, A; Provost, D; Versigny, A | 1 |
Caussade, F; Cazes, M; Cloarec, A; Desangle, V; Provost, D; Virone-Oddos, A | 1 |
Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
Mutschler, E; Palm, D; Soldner, A; Spahn-Langguth, H | 1 |
3 trial(s) available for up 269-6 and angiotensin ii
Article | Year |
---|---|
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Topics: Administration, Oral; Adult; Aldosterone; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Humans; Male; Plethysmography; Pyrimidines; Renin; Tetrazoles | 1995 |
Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Enalapril; Heart Rate; Humans; Male; Pyrimidines; Radioimmunoassay; Renin; Tetrazoles | 1995 |
A radioreceptor assay for the analysis of AT1-receptor antagonists. Correlation with complementary LC data reveals a potential contribution of active metabolites.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Proteins; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Imidazoles; Losartan; Male; Placebos; Pyrimidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Reference Values; Sensitivity and Specificity; Tetrazoles | 1998 |
4 other study(ies) available for up 269-6 and angiotensin ii
Article | Year |
---|---|
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Biphenyl Compounds; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle, Smooth, Vascular; Pyrimidines; Radioligand Assay; Rats; Tetrazoles | 1995 |
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dogs; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Species Specificity; Tetrazoles; Vasoconstrictor Agents | 1995 |
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cell Division; Imidazoles; In Vitro Techniques; Losartan; Muscle Proteins; Muscle, Smooth, Vascular; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Wistar; Stimulation, Chemical; Tetrazoles | 1997 |
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 1997 |